521.60 CHF

Opening hours: 09:00 - 17:20 (Central European Standard Time: 11/22/2024 3:16:24 AM)
Exchange closed, opens in 5 hours 43 minutes
1.09 CHF (1.09%)
-4.19 CHF (-4.19%)
-0.72 CHF (-0.72%)
0.93 CHF (0.93%)
51.03 CHF (51.03%)
60.70 CHF (60.70%)
446.75 CHF (446.75%)
891.12 CHF (891.12%)

About Lonza Group Ltd

Market Capitalization 40.24B

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. This segment also supports customers across various aspects of design, development, and manufacturing, including particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.

Headquarters (address)

Muenchensteinerstrasse 38

Basel 4002

Switzerland

Phone41 61 316 81 11
Websitehttps://www.lonza.com
Employees17,834
SectorHealthcare
IndustryDiagnostics & Research
TickerLONN
ExchangeSwiss Stock Exchange
CurrencyCHF
52 week range315.60 - 589.40
Market Capitalization40.24B
Dividend yield forward3.12 %
Dividend yield forward Switzerland (ID:153, base:169) 13.52 %
P/E trailing70.37
P/E forward30.95
Price/Sale6.01
Price/Book4.26
Beta0.640
EPS7.93
EPS Switzerland (ID:153, base:185) 29.31

Dividend growth streak

Lonza Group Ltd has raised their dividend 1.00 years in a row. This is below the 4.478497 year average in the 'Diagnostics & Research' industry

Forward Annual Dividend Yield

Forward Annual Dividend Yield: Lonza Group Ltd has raised their dividend 3.12 years in a row. This is below the 41125.084400 year average in the 'Diagnostics & Research' industry

Compound Average Growth Rate 3 Years

Compound Average Growth Rate 3 Years: Lonza Group Ltd has raised their dividend 8.37 years in a row. This is below the 24.014500 year average in the 'Diagnostics & Research' industry

Compound Average Growth Rate 5 Years

Compound Average Growth Rate 5 Years: Lonza Group Ltd has raised their dividend 4.94 years in a row. This is below the 12.586200 year average in the 'Diagnostics & Research' industry

Compound Average Growth Rate 10 Years

Compound Average Growth Rate 10 Years: Lonza Group Ltd has raised their dividend 5.80 years in a row. This is below the 10.156100 year average in the 'Diagnostics & Research' industry

Payout Ratio

Payout Ratio: Lonza Group Ltd has raised their dividend 50.31 years in a row. This is below the 146.971700 year average in the 'Diagnostics & Research' industry

Dividend growth streak

Lonza Group Ltd has raised their dividend 1.00 years in a row. This is below the 4.478497 year average in the 'Diagnostics & Research' industry

Forward Annual Dividend Yield

Forward Annual Dividend Yield: Lonza Group Ltd has raised their dividend 3.12 years in a row. This is below the 41125.084400 year average in the 'Diagnostics & Research' industry

Compound Average Growth Rate 3 Years

Compound Average Growth Rate 3 Years: Lonza Group Ltd has raised their dividend 8.37 years in a row. This is below the 24.014500 year average in the 'Diagnostics & Research' industry

Compound Average Growth Rate 5 Years

Compound Average Growth Rate 5 Years: Lonza Group Ltd has raised their dividend 4.94 years in a row. This is below the 12.586200 year average in the 'Diagnostics & Research' industry

Compound Average Growth Rate 10 Years

Compound Average Growth Rate 10 Years: Lonza Group Ltd has raised their dividend 5.80 years in a row. This is below the 10.156100 year average in the 'Diagnostics & Research' industry

Payout Ratio

Payout Ratio: Lonza Group Ltd has raised their dividend 50.31 years in a row. This is below the 146.971700 year average in the 'Diagnostics & Research' industry

CleverShares.com|
2024 ©

1.0.9089.36765